HomeHealth NewsFDA-approved nasal spray for severe depression can lead to remission

FDA-approved nasal spray for severe depression can lead to remission

January 27, 2025

- Advertisement -

The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

Major depressive disorder (MDD) is the most commonly diagnosed mental disorder globally.
The amount of people with MDD continues to increase every year.
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral…

Click here to view the original article.

Tags
medicalnewstoday.com

- Advertisment -

How the Ford Mustang muscled its way to the top

Ricky Ponting dragged into ugly on-field exchange between Matthew Wade and Sam Billings during BBL final

FDA-approved nasal spray for severe depression can lead to remission

Recently Viewed

Up 218% in a year, Mineral Resources shares sinking today amid mine closure news

Hair Stylist Kevin Murphy On The 2026 Red Carpet Trends

Ronaldinho Joins Ravenna FC in a Bold New Era for Football

Child safety changes risk separating Australia’s First Nations children from their culture – and causing even more harm

FEATURED

Great White shark bites fishing boat off Sunshine Coast

Volcanic cloud from Whakaari White Island halts flights

Great Koala Count: Aussies urged to track sightings of iconic marsupials

POPULAR POSTS

The fuel crisis has hit the Pacific hard. The region is responding – but tough choices lie ahead

‘Just leave him’: Neil the Seal incident sparks public backlash over handling of Tasmanian icon

Man, 29, charged after beauty clinic firebombed, IEDs seized in Concord West

POPULAR CATEGORY

FOLLOW US

FDA-approved nasal spray for severe depression can lead to remission

RELATED ARTICLES

Recently Viewed

FEATURED

POPULAR POSTS

POPULAR CATEGORY

FOLLOW US